Results 101 to 110 of about 46,198 (239)

Long‐term outcomes following modified Blalock–Taussig–Thomas shunt placement in 13 dogs with cyanotic congenital heart disease

open access: yesJournal of Small Animal Practice, EarlyView.
Objectives To describe long‐term outcome and owner‐perceived quality of life in dogs with cyanotic congenital cardiac disease undergoing modified Blalock–Taussig–Thomas shunt procedure. Materials and Methods Medical records of dogs that underwent Blalock–Taussig–Thomas shunt between 2009 and 2025 at a small animal referral hospital were retrospectively
M. Rossanese, J. Hannabuss, D. Brockman
wiley   +1 more source

Molecular Links Between Heat Stress and DNA Damage Response in Plants

open access: yesPlant, Cell &Environment, EarlyView.
ABSTRACT Climate change poses a major threat to agricultural productivity and, consequently, to global food security. Among the consequences of climate change, heat stress (HS) has emerged as a critical factor limiting crop performance. This has stimulated extensive research over the past decade to elucidate the molecular and physiological mechanisms ...
Adrian Calves‐Ubach   +1 more
wiley   +1 more source

Hydroxyurea Therapy in Thalassemiaa

open access: yesAnnals of the New York Academy of Sciences, 1998
Abstract: The clinical effectiveness of Hydroxyurea in thalassemia is still controversial. The present paper puts together the authors' experience in two groups of patients with thalassemia intermedia and sickle cell/β‐thalassemia treated with varying dosages of hydroxyurea over several months. A third group received hydroxyurea along with recombinant
Loukopoulos, D.   +8 more
openaire   +3 more sources

Effect of Combined Hydroxyurea and Chelation Therapy in Reducing Serum Ferritin Level, Liver and Spleen Size in Transfusion Dependent Thalassaemia Major Patients.

open access: yesJournal of Rawalpindi Medical College, 2019
Background: To compare hydroxyurea plus iron chelation therapy with iron chelation therapy alone in controlling iron overload in children with beta thalassaemia major.
Tatheer Zahra   +2 more
doaj  

The sickling pressure index predicts hemoglobin S target achievement during chronic red cell exchange in sickle cell disease

open access: yesTransfusion, EarlyView.
Abstract Background Chronic automated red cell exchange (RCE) reduces hemoglobin S (HbS) in patients with sickle cell disease (SCD), but procedural success varies across patients in ways standard exchange parameters do not explain. We introduce the Sickling Pressure Index (SPI), derived from each patient's daily rate of HbS rise (ROR) and daily rate of
Austin Choi   +3 more
wiley   +1 more source

Qualitative Analysis of Hydroxyurea

open access: yesDrug Analytical Research
Hydroxyurea (HU) is a cytostatic agent with antineoplastic activity and it has great clinical efficacy in the treatment of sickle cell disease. HU is part of the National Relation of Essential Medicines of Brazil and despite of its clinical importance, only the Portuguese, American and European Pharmacopoeias present monographs for this medicine.
Santos, Stéfanno Souza   +3 more
openaire   +8 more sources

Hydroxyurea induces the eNOS-cGMP pathway in endothelial cells

open access: yes, 2006
Hydroxyurea is a cell-cycle-specific drug that has been used to treat myeloproliferative diseases and sickle cell anemia. We have recently shown that hydroxyurea, like nitric oxide (NO)-donor compounds, increased cGMP levels in human erythroid cells.
Stojilković, Stanko S.   +6 more
core   +1 more source

Effect of hydroxyurea on the intracellular multiplication of Toxoplasma gondii, Leishmania amazonensis and Trypanosoma cruzi

open access: yesBrazilian Journal of Medical and Biological Research, 2003
Toxoplasma gondii, Leishmania amazonensis and Trypanosoma cruzi are obligate intracellular parasites that multiply until lysis of host cells. The present study was undertaken to evaluate the effect of hydroxyurea (an inhibitor of cell division at the G1 ...
E.J.T. Melo, H.J. Beiral
doaj   +1 more source

The Presence and Percentage of Circulating Nucleated Red Blood Cells Reveal Distinct Characteristics in Adults With Sickle Cell Disease

open access: yesAmerican Journal of Hematology, Volume 101, Issue 12, Page 2961-2975, December 2026.
ABSTRACT Although circulating nucleated red blood cells (cNRBCs) have previously been detected in patients with sickle cell disease (SCD), their prevalence and clinical significance during steady‐state disease have not been established. We retrospectively analyzed 270 adults with an SS or Sβ0‐thalassemia genotype.
Ugo Boccadifuoco   +7 more
wiley   +1 more source

Thrombocytapheresis for Extreme Thrombocytosis: A 20‐Year Single‐Center Experience With Acute and Chronic Use in Myeloproliferative Neoplasms

open access: yesJournal of Clinical Apheresis, Volume 41, Issue 6, December 2026.
ABSTRACT Thrombocytapheresis is an established adjunctive therapy for rapid platelet cytoreduction in patients with extreme thrombocytosis, particularly in myeloproliferative neoplasms (MPNs), where it is typically used alongside cytoreductive pharmacotherapy. Real‐world longitudinal data describing utilization, effectiveness, and safety remain limited.
Homayemem K. Weli   +2 more
wiley   +1 more source

Home - About - Disclaimer - Privacy